Concepedia

Publication | Open Access

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China

DOIFull Paper Access

16

Citations

29

References

2020

Year

Wen Gao, Yuan Jian, Juan Du, Xiaozhe Li, Huixing Zhou, Zhiyao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li,
Cancer Medicine

Abstract

In conclusion, 1q21 gain is an adverse prognostic factor for MM patients received ASCT.

References

YearCitations

Page 1